FDA warned tainted syringe maker

FDA sent a warning letter to a North Carolina syringe manufacturer, notifying of "several significant violations" in its quality control system, two years before its needles triggered an outbreak of illnesses that prosecutors say led to at least five deaths, the News & Observer reports. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.